Disease panels - StarSEQ - The Nucleotide Specialists
Illumina Trusight Myeloid Panel validation
Poor risk-AML
TruSight Myeloid Sequencing Panel
Biomedicines | Free Full-Text | Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing
Development and validation of a targeted gene sequencing panel for application to disparate cancers | Scientific Reports
TruSight One Sequencing Panels | Covering many disease-relevant genes
Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms | PLOS ONE